Article info
PDFResearch paper
No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 month follow-up study
- Correspondence to Dr Francesca Rinaldi, Multiple Sclerosis Centre, First Clinic of Neurology, Department of Neuroscience, University Hospital of Padova, via Giustiniani 2, Padova 35128, Italy; dr.francesca.rinaldi{at}gmail.com
Citation
No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 month follow-up study
Publication history
- Received December 7, 2009
- Revised February 21, 2010
- Accepted February 23, 2010
- First published June 14, 2010.
Online issue publication
February 21, 2018
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.